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Abstract
The acute phase protein (APP) response is an early systemic sign of disease, detected as substantial changes in
APP serum concentrations and most disease states involving inflammatory reactions give rise to APP responses. To
obtain a detailed picture of the general utility of porcine APPs to detect any disease with an inflammatory
component seven porcine APPs were analysed in serum sampled at regular intervals in six different experimental
challenge groups of pigs, including three bacterial (Actinobacillus pleuropneumoniae, Streptococcus suis, Mycoplasma
hyosynoviae), one parasitic (Toxoplasma gondii) and one viral (porcine respiratory and reproductive syndrome virus)
infection and one aseptic inflammation. Immunochemical analyses of seven APPs, four positive (C-reactive protein
(CRP), haptoglobin (Hp), pig major acute phase protein (pigMAP) and serum amyloid A (SAA)) and three negative
(albumin, transthyretin, and apolipoprotein A1 (apoA1)) were performed in the more than 400 serum samples
constituting the serum panel. This was followed by advanced statistical treatment of the data using a multi-step
procedure which included defining cut-off values and calculating detection probabilities for single APPs and for
APP combinations. Combinations of APPs allowed the detection of disease more sensitively than any individual
APP and the best three-protein combinations were CRP, apoA1, pigMAP and CRP, apoA1, Hp, respectively, closely
followed by the two-protein combinations CRP, pigMAP and apoA1, pigMAP, respectively. For the practical use of
such combinations, methodology is described for establishing individual APP threshold values, above which, for
any APP in the combination, ongoing infection/inflammation is indicated.
Introduction
The acute phase protein (APP) response is an innate reac-
tion towards tissue injury and follows rapidly (6-12 h)
after onset of any disease compromising tissue homeosta-
sis, for example infections, trauma, inflammation with var-
ious etiologies and some tumors. It can also be induced by
injection of microbial molecules (peptidoglycan, lipopoly-
saccharide) and pro-inflammatory cytokines [1-3]. The
APP response involves substantial changes in the serum
concentrations of numerous proteins, mainly as a result of
changes in their hepatic synthesis rates, although other
organs and tissues also show local APP responses [4]. The
APPs are typically present in the μg/mL to mg/mL range
in serum and plasma from an affected individual.
The APP response is thus a robust indicator of disease
and easily measurable in a blood sample. It has been
used as a very useful diagnostic tool for many years
especially in human medicine [5-7] but also increasingly
in veterinary medicine [8], especially for companion and
sports animals [9,10]. We have characterized the APP
response in pigs undergoing experimental infections
[11-15] and the correlation between APP concentrations
and disease in pigs in herds of different health status
has also been studied [16-22]. It is well established that
some APPs react to a lesser extent than others to the
same infection/inflammatory stimulus [8] reflecting dif-
ferent induction sensitivities of different APPs. Conver-
sely, APPs may also react differently to different types of
stimuli as reported for SAA (serum amyloid A), Hp
(haptoglobin) and alpha-1-acid glycoprotein in cattle,
which were all found to be more sensitive indicators of
acute than of chronic inflammation [23,24]. Other
examples of this include porcine Hp reflecting more clo-
sely the extent of lung damage in respiratory diseases
than CRP (C-reactive protein) [25], pigMAP (pig major
acute phase protein) that was reported not to react to
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infection with PRRSV (porcine respiratory and repro-
ductive syndrome virus) in naturally infected pigs [18],
and increased Hp being associated with lesions due to
enzootic pneumonia caused by Mycoplasma hyosynoviae
but not with lesions due to pleuritis (caused by Actino-
bacillus pleuropneumoniae) at slaughter [16]. The use of
more than one APP to increase the sensitivity of disease
detection was indicated in some of these studies [18,25]
and generalized in the suggestion by Gruys et al. [26] of
using both rapidly reacting as well as slowly reacting
APPs for detection of disease with increased sensitivity.
Although much useful information has been gained
from these studies, here we seek to answer the question
of which combination of pig APPs can be used generally
to give the most sensitive detection of ongoing disease
in the pig. The aim of the study was therefore to define
combinations of APPs that can be tested for use in real
life monitoring of infections in pig herds where, typically
neither the nature of infection nor the course of the
infection is known. As explained above, the threshold
for initiating an APP response varies between proteins
and diseases, as does the speed at which an acute phase
reaction resolves. In addition to this, the magnitude of
the reaction is also dependent on the APP/disease com-
bination. We therefore studied the acute phase response
of a number of specific pig APPs to several relevant
infectious agents as well as to aseptic inflammation in
experimental groups of pigs. The choice of APPs was
based on the following criteria: the acute phase changes
of the APPs should be well described, substantial and
reproducible, and reliable assays should be generally
available for their measurement in serum. Furthermore
both positive and negative APPs should be included.
The serum panel employed consisted of more than 400
samples, obtained from three bacterial, one viral, and one
parasitic infection and one aseptic inflammation group,
including infections with the prevalent pathogenic agents
Actinobacillus pleuropneumoniae (A.p.), Streptococcus
suis (S. suis), Toxoplasma gondii (T. gondii), Mycoplasma
hyosynoviae (M. hyos.), porcine reproductive and respira-
tory syndrome virus (PRRSV) and as a model inflamma-
tion, pigs injected aseptically with turpentine.
Immunochemical analyses of seven different acute phase
proteins, four positive (CRP, Hp, pigMAP and SAA) and
three negative (albumin (Alb), transthyretin (TTR), and
apoA1) were performed on all samples using the best
available assays in four different European laboratories.
Advanced statistical treatment of the data was performed
in a two-step procedure, including defining cut-offs for a
positive reaction and calculating detection probabilities for
single APPs as well as for all possible APP combinations
in order to select the combination of APPs that was most
sensitive for detecting any of the infections/inflammation
by strictly objective criteria.
By selecting APP’s that complement each other during
the progression of an infection, we aimed to construct a
measure of infection that was more sensitive than any
individual APP, over a wide period of the disease
progression.
Materials and methods
Animal groups
Test serum samples were obtained from consecutive
time points from a number of well-controlled and well-
characterized experimental infection experiments as well
as from a group of pigs undergoing induced aseptic
inflammation. Serum samples were obtained prior to
and from early, intermediate and late time points during
infection/inflammation. Sampling and experimental
groups were defined as follows: pigs should be more
than one month of age, the whole infection period (pre-
infection, during infection, post-infection) should be
covered by the sampling, a statistically adequate number
of samples/animals should be included for each infec-
tion, data on clinical signs and pathology should be
available, and samples from subclinically infected and
virus-infected pigs should be included.
All Danish pigs were from specific pathogen free (SPF)
herds. Breeds were Danish Yorkshire/Danish Landrace (for
the S. suis and T. gondii groups, see below) or crossbreds
between Yorkshire/Landrace sows and Hampshire/Duroc
boars (A.p. and M. hyos. groups) and the age was from 4/5
weeks and upwards (see below). Spanish pigs were used for
the inflammation group and were crossbreds between
Large White, Landrace and Pietrain pigs and 20 weeks of
age. Before inoculation, pigs were acclimatized for at least
1 week in isolation units in groups of 3-6 animals with free
access to water, and fed commercial feed without antibiotic
growth promoters. All animal experiments were conducted
in accordance with local legislation (Danish Animal Experi-
ments Inspectorate and Ethical Committee for Animal
Research at the University of Zaragoza) and were executed
according to best practices and legislation with veterinary
supervision to avoid unnecessary suffering.
S. suis: Five SPF pigs with no history of Streptococcus
suis serotype 2 infection and approx. 6 weeks of age
were infected by subcutaneous injection with a S. suis
serotype 2, ribotype I isolate (strain SS02-0119)[27],
1 mL (1010 CFU) in the back of the neck. Blood samples
were obtained at days -8, 0, 1, 2, 5, 8, 12 and 14 after
inoculation (pi). All pigs were euthanized and necrop-
sied at day 14 pi.
A.p.: Twelve pigs, approx. 8 weeks of age, were inocu-
lated (aerosol inhalation) [28] with an A. p. serotype 4
isolate. Blood samples were obtained at days 0, 3, 7, 10,
14 and 18 pi. When needed pigs were individually trea-
ted with antibiotics as described elsewhere [29]. Pigs
were euthanized and necropsied at day 49 pi.
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T. gondii: Five pigs, approx. 7 weeks of age, were
inoculated by i.v. injection with 104 tachyzoites of
T. gondii isolate SVS P14 [14]. Blood samples were
obtained at days 0, 3, 6, 8, 10, 14, 17 and 21 pi. Autopsy
was performed at day 27 pi.
PRRSV: Three pigs, 21 weeks of age, were inoculated
intranasally with a European PRRSV isolate (DK-111/92)
[30]. Blood samples were obtained at days -12(or -11), 0,
1, 2, 3, 4, 5, 7, 9, 11, 16 and 25 after inoculation.
M. hyos.: Nine pigs, 4½ weeks of age, were inoculated
intranasally with 2 × 1.5 mL of 1010 colour changing
units/ml of a cloned M. hyos. field strain (Mp 927cl)
[31] and blood samples from dpi -8, -2, 4, 6/7, 9, 12 and
14/15 were obtained.
Inflammation: Five pigs at 20 weeks of age were sub-
jected to aseptic inflammation by s.c. injection of
0.3 mL of turpentine/Kg body weight distributed equally
on each side of the neck [12] and blood samples were
obtained at 0, 12 h, 24 h, 36 h, 48 h, 3 days, 4 days,
7 days, 10 days and 14 days pi.
Blood samples
All blood samples were collected without anti-coagulant
and allowed to clot (at room temperature for 2 hours or
at 4°C overnight), before retrieval of serum by centrifu-
gation. Serum samples were stored below -20°C until
use.
Acute phase protein assays
The serum panel was blind-tested for the concentrations
of the positive APPs CRP, pigMAP, Hp and SAA and
the negative APPs apoA1, TTR and albumin, using
immunoassays.
Briefly, albumin, pigMAP and ApoA1 were deter-
mined by radial immunodiffusion [32] in 1% agarose
gels containing specific rabbit polyclonal antisera and
using a porcine serum as a secondary standard. The
concentration of these proteins in the secondary stan-
dard was previously determined by radial immunodiffu-
sion using the purified proteins as standard [12,33,34].
Intra- and inter-assay coefficients of variation were
below 5%.
The concentration of CRP, TTR, SAA and Hp was
measured by ELISA. Serum CRP was measured as
described in Sorensen et al. [15]. Microtiter plates were
coated with phosphoryl choline coupled BSA (BSA-CP)
and blocked with milk-powder in saline [35]. Samples
and standards were diluted in 50 mM Tris, 0.9% NaCl,
10 mM CaCl2, 0.1% Tween 20 (TBS-CT buffer), and
bound CRP was detected using an in-house anti-pig
CRP monoclonal antibody, followed by a peroxidase-
labelled goat-anti-mouse antiserum (Jackson Immuno
research Laboratories). All washings and additions of
secondary reagents were done in TBS-CT buffer. The
ELISA was developed using 50 mM citric acid, pH 4.0,
0.1 mM ABTS (2,2 Azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid)), 0.01% H2O2 as a color substrate and the
absorbance read at 405 nm. For the measurement of
TTR [11,15], microtiter plates were coated with serum
samples and purified human TTR (standard)(Sigma-
Aldrich, Poole, UK) and blocked with non-fat dried milk
in assay buffer (0.12 M NaCl, 0.02 M Na2HPO4, 0.1%
(v/v) Tween 20, pH 4.0). Bound TTR was detected with
sheep anti-human TTR antiserum, followed by a peroxi-
dase conjugated anti-sheep IgG (Sigma, Poole, UK). All
washing and detection steps were performed using assay
buffer. The ELISA was developed using TMB substrate
solution and the absorbance was read at 450 nm. Por-
cine Hp was analysed by sandwich ELISA essentially as
described before [15], using an in-house monoclonal
antibody against porcine Hp as the catching antibody.
A pool of pig serum calibrated against a porcine Hp
standard from Saikin Kagaku Co. Ltd. (Japan) was used
as in-plate standard. Samples were run in duplicate and
the absorbance was read at 490 nm subtracting 650 nm.
Finally, the concentration of SAA in the samples was
assessed by a sandwich ELISA from Tridelta Ltd. (Tri-
delta Development Ltd, Bray, Co. Wicklow, Ireland) in
accordance with the manufacturer’s instructions.
Statistical treatment of data (Detailed information
on this part of the work may be obtained from the
authors)
The aim of the statistical treatment was to establish a
measure of the ability of single APPs as well as any
combination of APPs to detect ongoing infection/
inflammation. To do this, detection probabilities, based
on cut-off values calculated for each APP, were com-
puted and evaluated for each of the five treatment
groups separately (sections “Univariate analysis for cal-
culation of single APP detection probabilities“ and “Mul-
tivariate analysis for calculation of combined APP
detection probabilities“), and for all of these weighted
together in a performance index for ongoing unknown
infection/inflammation (section “A global performance
index for unknown infection/inflammation“).
Univariate analysis for calculation of single APP detection
probabilities
Pre-treatment APP concentrations as derived from the
experimental data were used to estimate cut-off values
for each APP, i.e. the maximum (minimum for ApoA1,
albumin and TTR) value that the APP concentration is
expected to attain within a standard, one-sided 95%
confidence interval in an animal not undergoing an
infection. This was done by approximating the observed
pre-infection values with a normal distribution having
(estimated) mean μ and variance s2 for each APP
(except SAA, see below, Results). For a positive APP the
cut-off value is then μ +
√
(1 + 1/n)cσ, where c is the
Heegaard et al. Veterinary Research 2011, 42:50
http://www.veterinaryresearch.org/content/42/1/50
Page 3 of 13
0.95 percentile in the standard normal distribution, and
n is the number of animals in the data used to estimate
μ and s2. For a negative APP (i.e. ApoA1, albumin and
TTR), the cut-off is μ −
√
(1 + 1/n)cσ. An animal is
then classified as undergoing infection/inflammation if
the concentration of a given positive APP measured in a
sample from this animal is above the cut-off value for
the APP in question (and below for a negative APP).
This classification does not indicate anything about the
nature or the time course of the infection/inflammation.
In principle, the distribution of pre-infection values for
any given APP should not vary between the treatment
groups. This, however proved not to be the case here,
and therefore specific cut-off values had to be calculated
for each treatment group.
Cut-off values allowed the calculation of detection
probabilities. The detection probability is defined as the
probability, based on APP data, of classifying an animal
as undergoing infection/inflammation given that the ani-
mal is actually undergoing infection/inflammation as
defined by the experimental conditions. Thus, the detec-
tion probability equals the sensitivity of the measure-
ment(s) of the given APP in revealing ongoing infection/
inflammation using the experimentally defined infection/
inflammation status of the animal as the “gold stan-
dard”. For an APP measurement at time t after the start
of the infection/inflammation, having mean μt and var-
iance st2, the detection probability rt for a positive APP
is simply defined as the integral of the corresponding
normal density above the cut-off value, i.e.
ρt =
∫ ∞
μ+
√
(1+1/n)cσ
1√
2πσt
exp(− 1
2σ 2t
(x − μt)2)dx.
For negative APPs the modification of this expression
is obvious.
Multivariate analysis for calculation of combined APP
detection probabilities
A combined measurement of more than one type of APP
is expected to yield higher detection probabilities. To
quantify these gains in sensitivity, combined detection
probabilities needed to be calculated for all combinations
of two or more APPs. Albumin and TTR were disre-
garded due to inappropriate data structures for these two
APPs (see Results), and thus calculations were based on
Hp, CRP, ApoA1 and pigMAP only, using multivariate
analysis of pre-infection measurements of these four
APPs (using minus the pre-infection measurements for
the negative APP ApoA1). As these measurements
showed a clear pig effect they were approximated with a
multivariate normal distribution, in which variance-cov-
ariance parameters were allowed to vary freely. This
interdependence of APP concentrations was remedied by
establishing a theoretical transformation making the APP
concentration statistically independent. This was done by
arbitrarily sequencing the APPs as CRP first, then Hp,
ApoA1 and pigMAP. Then the difference between the
true mean and the conditional mean of any of the APP
measurements, given concentration measurements for
the remaining APPs in the sequence, was added. For one-
dimensional normal variables X and Y with means μx, μy,
variances sx
2, sy
2 and correlation r, these operations cor-
respond to subtracting (rsx/sy)( Y- μy) from X. For any
subset of the four APPs, a similar technique was applied,
simply by deleting the APPs not included in the subset
from the sequence of APPs. This transformation ren-
dered all co-variances between APP measurements zero
while retaining the original mean, and allowed the appli-
cation of standard techniques for independent stochastic
variables. Then, combined cut-off values were calculated
for each APP in a combination in order to keep the com-
bined probability that any APP in the combination show
a value above its combined cut-off value below 5% given
that the animal is not undergoing infection/inflamma-
tion. Thus, with Yj denoting the j’th transformed APP
measurement, which has (estimated) mean μj and var-
iance sj
2, the decision rule for classifying the animal as
‘infected’ on the basis of a subset J of the four APPs con-
sidered, will be that
for at least one j in J : Yj > μj + cσj,
where μj + csj is the combined cut-off value for APP j.
If J is all four APPs, c is equal to 2.23. For J consisting
of two or three APPs, c is equal to 1.95 and 2.12,
respectively.
Finally, the combined detection probabilities were cor-
rected for the fact that the independence-giving trans-
formation was estimated through the estimates of
variances and covariances from the multivariate normal
approximation of data. The transformation thus deviates
from the theoretical transformation, making the trans-
formed APP concentration measurements only approxi-
mately stochastically independent. Also, there was no
longer a fixed number of animals used to estimate the
variance, as the different treatment groups had different
numbers of animals. To deal with these two issues,
50 000 sets of 4 APP measurements for the same num-
ber of animals as in the experiment were simulated
from the estimated multivariate distribution, and trans-
formed as described above, using the transformation
derived from the empirical variance-covariance of the
simulated data. The value of c was then adjusted so that
5% of the simulations were classified as “infected”. Based
on the simulation study, we adjusted the c value for the
AP4 data with a factor of 1.18 while Mycoplasma, Strep.
suis, Toxoplasma and Inflammation did not require
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adjustment of the c value. Combined detection probabil-
ities were then estimated for all time points in the study
and for all combinations of the four APPs through simula-
tion studies (10 000 replications per time point and set of
APPs).
A global performance index for unknown infection/
inflammation
In practice, it may not be known which, if any, infection/
inflammation is present and at which stage. The detection
probabilities for single APPs as well as for APP combina-
tions computed above were all related to a specific infec-
tion/inflammation. To generalise this into an estimate of
the overall/global detection probability of a given APP or
APP combination, a global performance index was con-
structed, scoring the overall ability of any APP or APP
combination to detect the five types of infection/inflam-
mation that were considered in this study. This was based
on the assumptions that each of the five infection/inflam-
mation types were equally likely to be the one resulting in
significantly changed concentrations of any of the four
APPs, and that a sample from any time point in the study
period had the same probability of representing an animal
undergoing infection/inflammation. We considered the
detection probabilities as a function of time from infec-
tion/inflammation, and extrapolated the function linearly
between time points where data were available to the end
of the study period (see Additional file 1, Figure S2; note
that the end of the study period is defined by a point after
the ultimate time point equalling half the distance between
the ultimate and the penultimate time points, to put simi-
lar weights on all observations). At time 0 (time of infec-
tion/start of inflammation), the probability of incorrect
detection was set to 0.05, to conform to the 95% confi-
dence limit used for constructing detection probabilities.
For any combination of APPs, the probability of detection
at a uniformly random time point within the study period,
the performance index IJ for a subset J of the four APPs
then takes the form IJ =
1
5
5∑
i=1
1
i
i∫
0
fJ,i(t)dt, where the
summation extends over the five treatment groups, where
fJ,i is the extrapolated detection probability function for
the set of APPs J, for detecting infection/inflammation i,
and where ℓi is the length of the study period for infec-
tion/inflammation i.
Results
Disease development in the experimental groups
The inoculation strain was re-isolated from relevant tis-
sue in all infected animals and macroscopic lesions typi-
cal of the infection in question were found in all
animals upon necropsy, except one in the S. suis group,
and one animal in the A.p. group. With the exception of
the PRRSV group, general clinical signs such as fever
and loss of appetite were observed in all groups as were
specific clinical signs, in the relevant groups, such as
lameness (S. suis, M. hyos.), and coughing and sneezing
(A.p.). In short, clinical signs showed up early (within
first 24 h after inoculation) in the S. suis, A.p. and
inflammation groups and later in M. hyos. (most animals
at days 9-12 pi) and T. gondii (day 6 pi) groups. In the
PRRSV group all animals were asymptomatic even if
they all presented with PRRSV viraemia at days 3-4 pi.
Absence of clinical signs is typical of PRRSV-infected
animals of this age (21 weeks). For ethical reasons most
of the A.p. infected animals (11 of 12) were treated with
antibiotics at 27 h.
As the study objective was to establish the best APP
combination for indicating ongoing infection/inflamma-
tion, irrespectively of clinical signs, all animals were
included, even if severity of both clinical signs and
pathology varied between individual pigs. The specific
inoculation agent was re-isolated from all animals.
Acute phase protein response kinetics
Pre-challenge concentrations and the derived cut-off
values for Hp differed between different experimental
groups (see Table 1), while the within-group animal-to-
animal variation was not bigger than for the other APPs.
Very low pre-challenge concentrations of Hp were seen
for the A.p. and the M. hyos. groups while the T. gondii,
S. suis and inflammation groups showed much higher
pre-challenge values, and, consequently, higher cut-off
values. This indicated that pre-challenge conditions such
as age of pigs, origin and sanitary/microbial and stress
status of pigs and housing of pigs had a big effect on
Hp concentration. For some reason, this effect was not
as pronounced with the other APPs, although pre-
challenge effects were also clearly detectable with CRP
(Table 1). It can be noted that while the inflammation
and S. suis groups showed affected pre-challenge con-
centrations for all proteins, the A.p. group showed a
specific pre-challenge elevation of CRP and the T. gondii
group showed a specific elevation of Hp.
As seen in Figure 1a clear-cut APP responses for the
positive acute phase proteins CRP, pigMAP, Hp and
SAA were observed after infection with A.p., S. suis,
Table 1 Cut-off values as calculated for each of the
different experimental groups for four of the APPs
investigated (CRP: μg/mL, Hp: mg/mL, pigMAP: mg/mL,
ApoA1: mg/mL)
A.p. T. gondii M. hyos. S. suis Inflammation
CRP 23.70 14.41 0.55 30.82 19.39
Haptoglobin 0.004 1.54 0.007 0.94 0.85
pigMAP 0.45 0.59 0.82 1.55 0.93
ApoA1 1.84 2.06 2.92 0.96 1.62
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T. gondii as well as in response to inflammation, how-
ever infection with both PRRSV and M. hyos. generally
induced very low responses with the notable exception
of CRP which clearly increased after PRRSV infection.
For the other groups responses reflected the develop-
ment of clinical signs (see above), i.e. inflammation led
to a very quick response, while responses were gradually
slower in the order S. suis, A.p. and T. gondii. In addi-
tion, some variation between the responses of individual
APPs was evident. This was most clearly seen with SAA
which was an “all-or-none” responder with a large propor-
tion of the samples not having SAA above the detection
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Figure 1 Serum concentrations of the seven APPs from animals undergoing infection or inflammation as indicated, A: positive APPs,
B: negative APPs. Groups and group sizes: ■: Actinobacillus pleuropneumoniae (n = 12), ▲: Inflammation, (n = 5), ○: PRRS virus (n = 3), *:
Streptococcus suis (n = 5), ◊: Mycoplasma hyos. (n = 9), □: Toxoplasma gondii (n = 5). Error bars indicate SD.
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limit, and showing a very short-lived response. Also, there
were subtle differences between the reactions of CRP, pig-
MAP and Hp to the different infections; for example CRP
reacted more quickly in S. suis infected pigs than pigMAP
and - as mentioned above - was the only APP induced by
PRRSV. Also, Hp and CRP reacted more strongly to asep-
tic inflammation than did pigMAP, while Hp showed a
lower response to A.p. than to S. suis and T. gondii com-
pared to CRP and pigMAP which showed more similar
responses to these three pathogens (see Figure 1a). For the
negative APPs (Figure 1b), ApoA1 was the only protein
showing a clear and transient decrease occurring rapidly
for inflammation, S. suis and A.p. and later for T. gondii.
The responses of negative APPs albumin and TTR were
relatively weak with a large between-animal variation.
TTR did show a weak transient decrease with S. suis and
M. hyos. however was not affected by T. gondii, PRRSV
and A.p. infection. During inflammation the serum con-
centration of TTR decreased rapidly and stayed depressed
throughout the experiment. Albumin did appear to
decrease in the course of A.p. infection, however did not
react to any of the other infections.
Data from the PRRSV-infection experiment were
excluded from further analyses due to the evident inabil-
ity of this infection to induce any protein apart from
CRP (see Figure 1) and therefore not contributing to
defining the optimal APPs and APP combinations. The
full set of data for individual animals is shown in Addi-
tional file 1, Figure S1.
Detection probabilities for single APPs and APP
combinations
Estimated detection probabilities for each infection/
inflammation group are listed for CRP, Hp, pigMAP
and ApoA1 and for all combinations of these in Table
S1 (Additional file 1) and all single APP detection prob-
abilities are shown in Figure S3a (Additional file 1).
Albumin and TTR were not included due to their large
between-animal variation and inconsistent responses,
and SAA was also excluded, as calculation of a statisti-
cally meaningful cut-off value for this protein was not
possible due to the pre-infection concentrations being
below the detection limit of the assay and thus having
zero variance.
An example on the correlation between detection prob-
abilities and actual APP concentrations with the clinical
phase during infections is shown for haptoglobin in
Figure 2 for the S. suis and T. gondii groups. As can be
seen, the detection probabilities quite accurately reflect
the much narrower clinical phase for the T. gondii infec-
tion as compared to the S. suis infection.
Combined detection probabilities for APP combinations
yielded a broader window of detection of all of the infec-
tion/inflammation groups (see Figure S3, Figure S4 and
Table S1 (Additional file 1)). Figure 3 shows examples of
detection probabilities going from one-dimensional to mul-
tivariate and showing the worst and the best one-protein
APP, and the best two-, three- and the four-protein APP
combination for all experimental groups. For A.p., there
was not much difference between using the best single
APP and using any of the optimal APP combinations
while, for the inflammation group there was always an
effect of increasing the number of APPs and for the inflam-
mation group there was always an effect of increasing the
number of APPs (Figure 4a). Figure S3b (Additional file 1)
shows that for M. hyosyn., there was a big gain in going
from one to two APPs but not much gain in increasing
from two APPs to three or four, and for S. suis, there was
an effect of using two APPs instead of one, but not much
effect in increasing the number of APPs to three, although
increasing it all the way to four APPs did have an effect. In
the same figure it is seen that for T. gondii, there was no
effect in increasing to two APPs, but there was effect of
increasing the combination to three or four APPs. The full
set of detection probability curves for all APP combinations
is shown in Additional file 1, Figure S4.
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Figure 2 Haptoglobin as induced by Toxoplasma gondii (upper)
and Streptococcus suis (lower) infections depicted as
haptoglobin concentrations (solid curve) and by haptoglobin
detection probabilities (broken curve). Clinical phase (delimited
by the vertical lines) is defined as the time period in which at least
one animal in the group showed clinical signs. Horizontal line
indicates the cut-off.
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Figure 3 Probability curves for worst (ApoA1) and best (pigMAP) overall performing single APP for all experimental groups
combined, compared to best two-APP (CRP, pigMAP), three-APP (CRP, apoA1, pigMAP) and the one four-APP combination for each of
the experimental groups.
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Figure 4 Example of detection probabilities for best single and combined APPs with two experimental groups and global
performance indexes for all single and combined APPs. A: Two examples of detection probability curves for best performing APP or APP
combination for one protein, two proteins, three proteins and four proteins for two different experimental groups, inflammation (left), and A.p.
(right). B: Bar graph showing global performance indexes for all single proteins and all multiple protein combinations, stars indicating the best
performing APP or APP combination in each group (also see Additional file 1, Table S2).
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Overall performance of APPs and APP combinations
(global performance index)
Estimated global performance indexes are shown in
Table S2 (Additional file 1) and in Figure 4b. As the
detection probability was fixed at 0.05 at time 0, the
values in Table S2 (Additional file 1) should be com-
pared with the upper bound of 0.935, which is due to
the study design.
The average of the effect of increasing the number of
APPs in the measurements was reflected in the increase
in the global detection index for the best single, two-,
three- and the four-APP combination, which were 0.63,
0.81, 0.84 and 0.89, respectively (graphically depicted in
Figure 4b, also see Additional file 1, Table S2). This glo-
bal performance of APPs and APP combinations was
calculated by summing areas under the curve for detec-
tion probability curves for all infection/inflammation
groups, for each APP and APP combination as described
above. The best two-protein combination was CRP and
pigMAP (0.81) closely followed by apoA1 and pigMAP
(0.78), while the best three-protein combination was
CRP, apoA1 and pig MAP (0.84), with the four-APP
combination only slightly better (0.89). Thus, both of
the best three-APP combinations and the four-APP
combination were only marginally better than the CRP,
pigMAP combination.
Discussion
The data reported here give a wealth of information on
the response of different APPs to different infections in
the pig, complementing earlier studies in experimental
models [11-15] and suggesting ways of using APPs for
monitoring infections when type of the infection(s) as
well as the infection starting points are unknown. The
aim was to define the combination of APPs detecting any
infection/inflammation with the highest possible sensitiv-
ity. The sensitivity of a given APP or APP combination
for general detection of infection/inflammation will
depend on the generality of the response of the APP(s) in
question (the consistency of the response in a high pro-
portion of animals exposed to a range of different - rele-
vant - types of infections and inflammatory states), the
kinetics of the response (the rapidity, peak time and
extent of the response) and the between-animal variation
(the extent to which the significance of the response is
affected by variations in pre-infection levels and in
response levels between individual pigs).
The approach taken here is general, not incorporating
clinical data or taking biological differences between dif-
ferent infections into account, although they clearly give
rise to different APP responses. The idea is that it would
be beneficial if the APP measurement could also indicate
subclinical infection (APPs have the potential to do just
that, see for example Karreman et al. [36], Sorensen et al.
[15] and Gerardi et al. [37]). It is also assumed that any
combination of APP measurements giving a maximum
detection probability as defined here, i.e. with no refer-
ence to occurrence of clinical signs and/or pathological
changes, will also be the most globally sensitive combina-
tion for demonstrating any infection/inflammation, be it
clinical or subclinical. In addition, the experiments
included here are not comparable with respect to fre-
quency and level of detail in recording clinical signs.
From this it follows that data were treated under the
assumption that all animals included in an experimental
group were subject to the same course of infection/
inflammation. Accordingly, the results of the calculations
do not indicate to which extent the APPs can differenti-
ate between individual animals being differently affected
by the infection/inflammation (as e.g. indicated by differ-
ences in clinical responses). In other words, differences
in reaction to the (same) stimulus by the individual pigs
were incorporated into the calculations and accounted
for the majority of the variations in the treatment groups.
The experimental groups covered a broad and relevant
range of infections, and data on CRP, Hp, ApoA1 and
pigMAP concentrations were included; Albumin and
TTR concentrations showed a large animal-to-animal
variation and negligible detection probabilities (not
shown) and thus were excluded from further study, and
for SAA a cut-off value could not be defined as its pre-
infection serum concentration was below the detection
limit of the assay (6 μg/mL). Data from the PRRSV
group were excluded from analysis as only CRP showed
any substantial response in this group.
The statistical treatment of data comprised a two-step
procedure first defining cut-off values for the individual
APPs and then deriving detection probabilities for single
APPs and for combinations of APPs by multivariate ana-
lysis, both of these for each experimental group. As can
be seen in Figure 3, the detection probability curves for
the single worst (apoA1) and single best (pigMAP) per-
forming APPs and for the best two-APP, three-APP and
the single possible four-APP combination, clearly show
that detection sensitivities for most challenge groups are
much improved when increasing the number of APPs.
To generalize this, a measure of overall (global) detec-
tion sensitivity for all of the experimental groups
involved was constructed based on the summed area
under the curve averaged over all of the infections in
order to compare the global performance indexes for the
different APP combinations. This measure gives the
average probability of detecting, using the APP combi-
nation in question, any of the infections with all 5 infec-
tions equally probable.
This evaluation showed that APP combinations
allowed the detection of disease more sensitively than
any individual APP (best individual APP is pigMAP
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(0.63)). The global performance indexes for the best
two-APP combination, the best three-APP combination
and the four-APP combination were within a close
range (0.81, 0.84 and 0.89, respectively) and close to the
upper limit of the index (0.935). Indeed, it seems worth-
while to consider the two-protein combinations (espe-
cially CRP, pigMAP (0.81) and apoA1, pigMAP (0.78)),
performing almost as well as the best three-protein
combination. The benefit of choosing the best three-
APP combination is that it includes both negative and
positive APPs. The Hp, pigMAP combination had a
similar global detection probability index (0.77), however
it might be advisable to avoid Hp as its cut-off differed
widely between the different treatment groups. Clearly,
pre-challenge history (age of pigs, origin and sanitary/
microbial status of pigs stress and housing of pigs) had
a bigger effect on Hp than on the other APPs investi-
gated. This confirms data reported on pig Hp in differ-
ent pig herds [20], showing higher variability than CRP
[16,17] and pigMAP [21]. Although cut-off values for
CRP also varied considerably between experimental
groups this was mostly due to one group having very
low pre-challenge levels (M. hyos.).
While providing suggestions for which APPs to com-
bine for sensitive detection of infection and inflamma-
tion in pigs, no generally applicable cut-off values,
neither single-APP cut-off values nor combined cut-off
values can be derived from this study. However, a
method is provided for calculating combined cut-off
values for each APP in an APP combination (see section
“Multivariate analysis for calculation of combined APP
detection probabilities“), based on pre-infection concen-
trations. Evidently, this favours the use of APPs that
show little variation between animals (by increasing the
detection probabilities for the APP in question) and
APPs that show little variation between groups (or
herds), by increasing the probability that a given cut-off
value calculated from the pre-infection data from a col-
lection of relevant samples is indeed applicable to the
set of samples being evaluated.
The approach described here enables the use of the
optimal APP combination for sensitive detection of
infection/inflammation, by measuring each APP in the
preferred combination and observing if any of the APPs
are above (or below for negative APPs) their respective
combination cut-off values. If specific circumstances
make certain APPs more practical and/or advantageous
to use than others, the methods presented here can also
be used to calculate combination cut-off values for such
a set of APPs.
Thus, a decision rule for defining an APP serum con-
centration as indicating infection/inflammation, irrespec-
tive of the type of infection or the time of disease
progression was established, different APP combinations
were evaluated and their optimally sensitive combina-
tions were identified. While the methods are general, the
results are dependent on the experimental structure that
was used to obtain the APP data. Furthermore, the data
were heterogeneous in the sense that it was not possible
to establish a pre-infection distribution independent of
infection type for each APP. Thus, for general, practical
use, the definition of cut-off values, based on relevant
pre-infection data is pivotal, necessitating that a relevant
group of non-infected animals are available and that
herd/management effects can be accounted for, as such
effects will also apply to all other pigs in the herd and
will vary from one APP to another (Hp being more sensi-
tive to these effects than the other APPs studied, see
above) [16,17,20,21]. Thus, although the present study as
well as that of other investigators for example Parra et al.
[18] provide values for normal, pre-infection concentra-
tions of a number of useful APPs it is recommended that
group/herd-specific data are always obtained and used in
order to define cut-off values. Such data may be derived
by continuous APP surveillance of herds in periods in
which the herd is free from disease.
In addition, to further corroborate the conclusions on
which APP combinations are generally optimal, future
studies should extend to more, relevant infections includ-
ing different types of (clinical and subclinical) viral infec-
tions, infections with helminths and bacterial infections
restricted to the mucosal surfaces. This would generate a
more complete picture of the possibilities and limitations
of the use of APPs for revealing infection and to possibly
define APP subsets that are particularly applicable to cer-
tain groups of infections and/or situations.
The potential of the method for analyzing APP data
from herds in which knowledge of infections is scarce
opens up new ways of classifying/certifying pig herds
with improved welfare. In addition this would allow
continuous, general screening of herds for health pro-
blems which may be followed up by traditional serologi-
cal methods if needed. In order to achieve the full
potential of this approach, validated and robust APP
assays and APP standards need to be generally available.
Additional material
Additional file 1: Supplementary data.All APP concentration data for
all treatment groups. All detection probabilities for all treatment groups
and for all APPs and their combinations. Performance index for APPs and
APP combinations.
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